Genetic counselors and patient advocates say more people are refusing genetic testing because they're uncertain of how it will impact their insurance.

Women with a family history of breast and ovarian cancer who are interested in getting genetically tested to gauge whether they have a heightened risk for the diseases should speak to a genetic counselor before getting tested, patient groups are advising their members.

This article has been updated to correct that Ellen Matloff is a plaintiff in AMP v. USPTO.

At a SACGHS meeting last week, FORCE said that Myriad Genetics sales representatives discourage doctors from referring patients to genetic counselors, and recommended the committee make recommendations for greater monitoring of such actions. SACGHS plans to invite Myriad to respond to the allegations.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.